Seres therapeutics reports q4 net loss of $18.8 mln

Seres therapeutics reports fourth quarter and full year 2019 financial results and corporate highlights.seres therapeutics - reported net loss of $18.8 million for q4 of 2019, as compared to a net loss of $21.3 million.

MCRB Ratings Summary

MCRB Quant Ranking